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Objective: To investigate the production of tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6) induced by live 
Gram-negative and Gram-positive bacteria in whole blood in vitro. 
Methods: In all, 49 different isolates were studied. Each of the 49 different isolates was incubated for 4 h with whole 
blood at a ratio of one monocyte per 1-5 bacteria. Plasma was then separated and frozen, and the concentrations of 
TNF-a and IL-6 were measured by enzyme immunoassays. 
Results: There was a positive correlation between TNF-a and IL-6 values, r=0.9. Gram-negative bacteria induced higher 
levels of both TNF-a and IL-6 than Gram-positive bacteria. Group G streptococci (GGS) induced higher levels of TNF-a 
than Streptococcus pneumoniae, Staphylococcus aureus, Staphylococcus epidermidis and group A streptococci (GAS). 
Klebsiella pneumoniae induced higher levels of TNF-a than Haemophilus influenzae, Escherichia coli and Neisseria 
meningitidis. GGS induced higher levels of IL-6 than Staphylococcus epidermidis, Staphylococcus aureus and GAS. 
When the relative amounts of cytokine induced by the strains were compared to serum concentrations measured on 
admission in patients with bacteremia caused by the same bacterial isolates there was no significant correlation. 
Conclusion: Species- and strain-related differences in cytokine-inducing properties were found which may have 
significance in  clinical infections. 
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INTRODUCTION 
Cytokines are important mediators in the inflammatory 
host response to bacterial infection. High levels of 
cytokines such as tumor necrosis factor-a (TNF-a) 
and interleukin-6 (IL-6) have been shown to correlate 
with severity in patients with bacteremic infections or 
sepsis syndrome [1,2], and in some clinical studies 
blood concentrations of TNF-a and IL-6 have been 
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shown to be higher in patients with infections caused 
by Gram-negative bacteriathan in those with infections 
caused by Gram-positive bacteria [l-31. The bacterial 
components able to induce cytokine production have 
been shown to be lipopolysaccharide (LPS) from 
Gram-negative organisms, and exotoxins, enterotoxins 
and cell wall constituents from Gram-positive bacteria 
[4-71. However, previous investigations have examined 
either bacterial components or heat- or antibiotic- 
killed bacteria and usually examined single bacterial 
species [4,6-131. 
In this paper we investigate the ability of different 
live Gram-negative and Gram-positive bacteria to 
induce the production of TNF-a and IL-6 in whole 
blood in vitro using a method previously published 
[10,12,13]. The aim was to study differences in 
cytokine-inducing abilities between different bacterial 
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species and to compare the relative values with the 
concentrations in blood obtained from patients with 
bactereniia caused by the same isolates. 
MATERIAL AND METHODS 
Bacteria 
Forty-four bacterial strains were clinical isolates from 
blood, and five (all Streptococcus pneumoniae) were isolates 
from the upper respiratory tract, in all representing 
eight different species which were obtained from the 
collection of frozen bacterial strains at  the Department 
of Clinical Microbiology, Orebro Medical Center 
Hospital. The strains and their characteristics are listed 
in Figure 1: the pneumococci were of serotypes 3 (two 
isolates), 6A, 9N, 18C, 19A, 196 22F, 33F and 35F; the 
meningococci were of serogroups A, BT2, BT4, BT15, 
C and 29E. Included in the 44 isolates from blood were 
the 25 isolates from the patients described below. 
The bacteria were thawed and grown on appro- 
priate media overnight and then two colonies were 
added to broth suitable for each bacterial species and 
grown on a shaker overnight. O n  the day of the 
experiment 5 mL of the bacterial suspension was 
diluted with phosphate-buffered saline (PBS, cat. no. 
10010-015, Gibco BRL, Life Technologies, UK) and 
centrifuged, the supernatant discarded and the pellet 
resuspended in PBS. This procedure was performed 
two times, and then the bacterial number was adjusted 
to a monocytehacterium ratio of 1 : 1-5 by counting in 
a Burker chamber. The bacterial viability was checked 
by culture on appropriate agar plates immediately 
before the experiments were started. 
Whole blood 
Venous blood was obtained from blood donors with 
compatible blood groups. For each experiment, six 
donors were used. The blood was sampled into tubes 
containing endotoxin-free heparin (Endotube ET, 
Chromogenix AB, Sweden) and the blood was then 
pooled in endotoxin-free tubes. Neutrophil, monocyte 
and lymphocyte counts were made using a CellDyn 
hematocytometer immediately after pooling and gentle 
mixing of the blood. 
In vitro stimulation experiments 
A method described previously [10,12,13] was used 
with minor modifications. Nine hundred microliters of 
whole blood with the addition of 100 pL of the 
bacterial suspension was incubated for 4 h at 37°C in 
5%) COz in sterile tubes (Kimble 12 X 75 mm sterile 
glass tubes, Labora, Sweden). The tubes were then 
put into iced water and immediately centrifuged; 
the plasma was separated and stored at -20°C until 
cytokine analysis was performed. Two negative controls 
(PBS and whole blood), and four positive controls 
(whole blood + 100 pg LPS and whole blood + 1 rig 
LPS) were included in each experiment. In total, nine 
experiments were performed. As different donor pools 
were used, the results are presented as a ratio of the 
amount of cytokine induced by the bacterial suspension 
and the amount induced by LPS in each experiment. 
For TNF-a the amount induced by the bacteria is 
divided by that induced by 1 ng LPS, and for IL-6 the 
amount of cytokine induced by the bacteria is divided 
by that induced by 10Opg LPS. The amount of 
cytokine produced by whole blood incubated with 
PBS was negligible in each experiment. 
Determination of TNF-a and 11-6 
Plasma was analyzed using TNF-a  and IL-6 ELISA kits 
from R&D Systems Europe, UK. Fetal calf seruni 
inactivated by heating at 56°C for 1 h from Invitro, 
Sweden (cat. no. 29-101-54) was used for dilution of 
the plasma samples. All samples were assayed once 
undiluted, and then samples with high values were 
diluted and retested. 
Endotoxin measurements 
The amount of endotoxin in each sample as well as in 
the reagents used in all the experiments was measured 
using a Limulus Amebocyte Lysate (LAL) test 
(COATEST, Chromogenix AB, Sweden). Samples 
with high values were diluted and retested. No endo- 
toxin was detected in samples stimulated with Grani- 
positive bacteria. The endotoxin concentrations found 
in the samples stiniulated with Gram-negative bacteria 
were variable but there were only weak correlations 
between the concentrations of cytokines and endo- 
toxin. 
LPS 
LPS from Esclzericlziu coli 0111:U4 was obtained from 
Sigma (St Louis, Mo.) and was used as positive control 
in the cytokme and endotoxin assays. 
Patients 
Ten patient? with Staphylococcus aureus bacteremia 
selected from 64 described previously [I 41 and 15 with 
Streptococcus pneumoniae, Eschevicliia coli or group A 
(n=2) or G (ri=3) heniolytic streptococcal bactereinia 
also previously reported [2] were included. 
Statistical methods 
Data are expressed as mean + 1 SD. When levels of 
cytokines in more than two groups were compared, 
one-way analysis of variance was used. Post hoc 
multiple comparisons were tested using the Bonferroni 
Kragsb jerg  e t  a l :  Cy tok ine  p roduc t i on  i nduced  by  bacter ia  i n  whole b l o o d  1 3 1  
test at  p<0.05. When two groups were compared, 
the unpaired Student’s t-test was used. Correlation was 
studied using the Pearson correlation test. The Statview 
4.01 (Abacus, Ca) software was used for the statistical 
calculations. 
Ethical considerations 
The study was approved by the local ethics committee. 
RESULTS 
The results are shown in Figure 1. There was a positive 
correlation between values obtained for TNF-cx and 
IL-6 ( ~ 0 . 9 1 ) .  
Production of TNF-a 
Gram-negative bacteria induced higher levels of TNF- 
a than Gram-positive bacteria (p<O.OOOl). Among the 
Gram-positive bacteria, group G hemolytic strepto- 
cocci (GGS) induced higher levels than all other 
Gram-positive isolates. In the group of Gram-negative 
bacteria, Klebsiella pneumoniae induced higher levels 
than Haemophilus infiuenzae (non-typeable or group b), 
E. coli and Neisseria meningitidis. E. coli induced higher 
levels than H .  infuenzae (non-typeable or group b) and 
N. meningitidis. 
Production of 11-6 
Gram-negative bacteria induced higher levels of IL-6 
than Gram-positive bacteria, (p<O.0001). Among the 
Gram-positive bacteria, GGS induced higher levels 
than Staphylococcus epidermidis, enterotoxin-producing 
Staphylococcus aureus and group A hemolytic strepto- 
cocci (GAS). There were no significant differences 
among IL-6 levels induced by the different Gram- 
negative bacteria. 
Comparison of in vitro and in vivo cytokine concentrations 
There was no significant correlation between cytokme 
concentrations produced in vitro and admission 
cytokine concentrations in patients with bacteremia 
with the same isolates, The mean values + 1 SD 
obtained in vitro are shown in Figure 2a, and the 
corresponding serum concentrations (mean + 1 SD) 
measured in patients with bacteremia with the same 
isolates are shown in Figure 2b. 
DISCUSSION 
Recent clinical studies [l-31 have demonstrated 
significant differences in blood cytokine levels in 
patients with different bacterial infections. In the 
present study, significant differences were also found in 
the capacity of different bacterial strains to induce 
TNF-cx and IL-6 production in whole blood in vitro. 
Significant differences were found between Gram- 
negative and Gram-positive bacteria but also between 
different species. 
As the ratios between monocytes and bacteria were 
the same during all the experiments, we believe that 
the differences found reflect differences between the 
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Figure 1 (a) Histogram showing mean values (+1 SD) of 
the ratios of production of TNF-a induced by the bacterial 
strain divided by that induced by 1 ng LPS. (b) Histogram 
showing mean values (+1 SD) of the ratios of production of 
IL-6 induced by the bacterial strain and that induced by 
100 pg LPS. SPU, Streptococcr*s pneumoniae, upper respiratory 
tract isolates, n=5; SP, Streptococcus pneumoniae, n=5; SE: 
Staphylococcus epidermidis, n=4; SfiE, Staphylococcus aureus, 
enterotoxin-producing, n=5; SA, Staphylococcus aureus, non- 
enterotoxin-producing, n=5; GGS, group G streptococci, 
n=3; GAS, group A streptococci, n=2; NTH, non-typeable 
HaemophiltAs injuenzae, n=3; Hib, H .  irzzccenzae type b, 
n=3;  NM, Neisseria meningitidis, n=6; KP, Klebsiella 
pneumoniae, n=3; EC, E. coli, n=5.  
AU strains are blood isolates except where indicated. 
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Figure 2 (a) Histogram showing mean values (+I SD) of the ratios of the amount of cytokine induced by the bacterial 
strains and that induced by LPS. (b) Mean (+1 SD) serum concentrations of TNF-CY and IL-6 measured on admission in 
patients with bactereniia caused by the same isolates as in (a). 
various species’ abilities to induce cytokine production. 
LPS is a powerful stiniulator of cytokine production 
[5,10,13] and is probably the main cause of the 
high ratios found for the Gram-negative bacteria. The 
difisrences found between the different Gram-negative 
strains may be due to differences in LPS content. 
Although there was a strong correlation between the 
levels of the two cytokines induced in vitro, relative 
differences were found between species of Grain- 
negative bacteria. Non-typeable (NT) H. inq’luenzae 
and H .  inznenzae type b induced similar TNF-a  
concentrations, but NT H .  infitrenzue was a far more 
potent inducer of IL-6 than H. injuenzae type b. 
Similarly, K. pneumonine induced high levels of TNF-a 
compared to E. coli, but E. coli was a more potent 
inducer of IL-6 production than K. pneuinoniae. Large 
intraspecies variation w a s  found within the group of 
N. merzingitidis isolates, as indicated by the size of the 
standard deviation. These results suggest that species as 
well as strain-specific differences in cytokine-inducing 
properties do exist. 
Various toxins produced by Gram-positive bacteria 
may induce cytokine production but we found no 
differences between enterotoxin-producing Stuphylo- 
COCCUS u w e w  and non-producing strains. GAS produce 
powerful toxins [15,16] but the two isolates studied in 
the present experiments induced lower levels of 
cytokines than did the three isolates of GGS. Whether 
these strains were toxin producers or not was not 
investigated. In addition, components of Gram-positive 
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bacteria such as cell wall parts may also induce inflam- 
matory responses, as was previously shown [4,6]. The 
possibility of LPS contamination was ruled out, as all 
samples with Gram-positive bacteria were negative for 
LPS in the LAL test. 
We found no differences in the cytokine levels 
induced by blood isolates of Streptococcus pneumoniae and 
isolates from the upper respiratory tract and similarly 
there was no difference between the levels induced 
by Staphylococcus epidermidir and Staphylococcus aureus, 
suggesting that usually non-pathogenic bacterial species 
have the potential to trigger an inflammatory response 
once they have reached the bloodstream. 
Comparing the levels induced in vitro with the 
concentrations found in vivo caused by the same 
bacterial isolates, we found no significant correlation. 
The largest variation was seen for Streptococcus pneu- 
moniae and the other streptococci. The five E. coli 
strains induced similar responses in vitro but larger 
variation was seen in vivo. Variation in the components 
of the immune response in cells and soluble mediators 
in the blood donor pool and in the individual patients 
are some possible explanations. The timing of the blood 
sampling in relation to the onset of symptoms in vivo 
may also influence the values obtained. Furthermore, 
other cells than circulating blood cells such as tissue 
macrophages, endothelial cells and epithelial cells may 
contribute to cytokine production in vivo [17-191, as 
may differences in the sensitivity of various cell lines to 
bacterial toxins. 
The in vitro experiments were terminated after 
4 h of incubation, as has been done in previous 
investigations [9,10,20]. Extending the period of 
incubation has been shown to give higher concen- 
trations. We did not investigate whether the relative 
differences found between different bacterial species 
would disappear if the period of incubation was 
extended to 24 or 48 h. 
In conclusion, we found significant differences 
between Gram-positive and Gram-negative bacterial 
species in their capacity to induce production of TNF- 
a and IL-6 in whole blood in vitro. Although we 
found a significant correlation between TNF-a and 
IL-6 production in vitro, some Gram-negative strains 
induced more TNF-a than IL-6 and other Gram- 
negative strains relatively more IL-6. We found no 
correlation between the cytokine levels induced in 
vitro and those found in vivo, which may be due to 
variability in the individual host inflammatory response 
to infection. 
Acknowledgments 
We thank Mats Fogelqvist and Ingemar Valfridsson for 
excellent technical assistance. 
References 
1. Casey LC, Balk RA, Bone RC. Plasma cytokine and 
endotoxin levels correlate with survival in patients with the 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
sepsis syndrome. Ann Intern Med 1993; 119: 771-8. 
Kragsbjerg P, Holmberg H, Vikerfors T. Dynamics of 
blood cytolune concentrations in patients with bacteremic 
infections. Scand J Infect Dis 1996; 28: 391-8. 
Cebon J, Layton JE, Maher D, Morstyn G. Endogenous 
haemopoietic growth factors in neutropenia and infection. 
Br J Haematol 1994; 86: 265-74. 
Bhakdi S, Klonisch T, Nuber P, Fischer W. Stimulation of 
monolune production by lipoteichoic acids. Infect Immun 
1991; 59: 4614-20. 
Bjork L, Andersson J. Ceska M, Andersson U. Endotoxln 
and Staphylococcus aureiis enterotoxin A induce different 
patterns of cytokines. Cytokine 1992; 4: 513-19. 
Heumann D, Barras C, Severin A, Glauser MP, Tomasz A. 
Gram-positive cell walls stimulate synthesis of tumor necrosis 
factor alpha and interleukin-6 by human monocytes. Infect 
Immun 1994; 62: 2715-21. 
Riesenfeld-Om I, Garcia-Bustos JF, Hoffmann MK, 
Tuomanen E. Production of interleukn-I but not tumor 
necrosis factor by human monocytes stimulated with 
pneumococcal cell surface components. Infect Immun 1989; 
57: 189C-3. 
Bayston K, Tomlinson M, Cohen J. In-vitro stimulation of 
TNF-a from human whole blood by cell-free supernatants 
of Gram-positive bacteria. Cytokme 1992; 4: 397-402. 
Arhti M, Kabat W, Yogev R. Antibiotic-induced bacterial 
killing stimulates tumor necrosis factor-a release in whole 
blood. J Infect Dis 1993; 167: 24C4. 
van der Poll T, Jansen J. Endert E, Sauenvein HP, van 
Deventer SJH. Noradrenahne inhibits lipopolysaccharide- 
induced tumor necrosis factor and interleulun 6 production 
in human whole blood. Infect lmmun 1994; 62: 2046-50. 
Houldsworth S, Andrew PW, Mitchell TJ. Pneumolysin 
stimulates production of tumor necrosis factor alpha and 
interleukm-1 p by human mononuclear phagocytes. Infect 
Immun 1994; 64: 1501-3. 
Klein NJ, Kalablilas P, Curtis N, Chan B, Heyderman RS, 
Levin M. Ex-vivo assessment of candidate anti-inflammatory 
agents in the treatment of Gram negative sepsis. Itnmunol 
Infect Dis 1994; 4: 33-5. 
Prins JM, Kuijper EJ, Mevissen MLCM, Speelman P, van 
Deventer SJH. Release of tumor necrosis factor dpha and 
interleukin 6 during antibiotic kdling of Eschmichia coli in 
whole blood: influence of antibiotic class, antibiotic concen- 
tration, and presence of septic serum. Infect Immun 1995; 
63: 2236-42. 
14. Soderquist B, Sundqvist K-G, Vikerfors T. Kinetics of 
interleukin-6, tumor necrosis factor-a and interleukin-1 
in patients with Staphylococcus atireus septicemia. Immunol 
Infect Dis 1994; 4: 235-42. 
15. Norrby-Teglund A, Norgren M, Holm SE, Andersson U, 
Andersson J. Similar cytokine induction profdes of a novel 
streptococcal exotoxin, MF, and pyrogenic exotoxins A and 
B. Infect Immun 1994; 62: 3731-8. 
16. Hackett SP, Stevens DL. Superantigens associated with 
staphylococcal and streptococcal toxic shock syndrome are 
1 3 4  Cl in ica l  M i c r o b i o l o g y  and  In fec t i on ,  V o l u m e  4 Number  3, March  1998 
potent inducers of tumor necrosis factor-P synthesis. J Infect 
Dis 1993; 168: 232-5. 
17. Jirik FK, Podor TJ, Hirano T, et al. Bacterial lipo- 
polysaccharide and inflammatory mediators augment IL-6 
secretion by human endothelial cells. J Immunol 1989; 142: 
18. Khair OA, Devalia JL, Abdelaziz MM, Sapsford KJ, Tarraf 
H, Davies RJ. Effect of Harmophilus ifijuenzae endotoxin 
on the Fynthesis of IL-6, IL-8, TNF-a and expression of 
ICAM-I in cultured human bronchial epithelial cells. Eur 
Kespir J 1994; 7: 2109-16. 
144-7. 
19. Trentin L, Garhisa S ,  Zanibello R, et al. Spontaneous 
production of interleukin-6 by alveolar macrophages from 
human immunodeficiency virus type 1-infected patients. 
J Infect Dis 1992; 166: 731-7. 
20. DeForge LE, Kenney JS, Jones ML, Warren JS, Remick DG. 
Biphasic production of IL-8 in lipopolysaccharide (LPS)- 
stimulated human whole blood. J Immunol 1992; 148: 
2133-41, 
